Prospects for Treatment of Pediatric Vitreoretinal Diseases with Vascular Endothelial Growth Factor Inhibition

ANTIANGIOGENIC THERAPY WITH INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY

(2009) HUGO QUIROZ-MERCADO et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

TREATMENT OF VASCULARLY ACTIVE FAMILIAL EXUDATIVE VITREORETINOPATHY WITH PEGAPTANIB SODIUM (MACUGEN)

(2009) POLLY A. QUIRAM et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Wnt/Frizzled signaling in angiogenesis

(2008) Marielba Zerlin et al.   ANGIOGENESIS

Intravitreous Bevacizumab as Anti–Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study

(2008) Lingkun Kong   ARCHIVES OF OPHTHALMOLOGY

Wnt Signaling in Angiogenesis

(2008) Nancy Parmalee et al.   CURRENT DRUG TARGETS

Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity

(2008) Shigeru Honda et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab

(2008) Mizuki Tagami et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease

(2008) Mehmet Çakır et al.   JOURNAL OF AAPOS

Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

(2008) Magali Saint-Geniez et al.   PLoS One

INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE II

(2008) HELEN A. MINTZ-HITTNER et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Vitreous Levels of Stromal Cell–Derived Factor 1 and Vascular Endothelial Growth Factor in Patients with Retinopathy of Prematurity

(2007) Kenan Sonmez et al.   OPHTHALMOLOGY